HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$17.49
Day range
$17.05 - $18.38
Year range
$6.88 - $74.49
Market cap
257.29M USD
Avg Volume
269.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.16M | 55.77% |
Net income | -22.65M | -33.84% |
Net profit margin | — | — |
Earnings per share | -1.08 | — |
EBITDA | -25.16M | -40.83% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 292.60M | 72.59% |
Total assets | 315.30M | 61.40% |
Total liabilities | 23.51M | -4.34% |
Total equity | 291.80M | — |
Shares outstanding | 14.26M | — |
Price to book | 0.90 | — |
Return on assets | -19.91% | — |
Return on capital | -20.69% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -22.65M | -33.84% |
Cash from operations | -20.77M | 4.05% |
Cash from investing | -45.04M | -250.48% |
Cash from financing | 4.00K | 100.06% |
Net change in cash | -65.82M | -3,837.37% |
Free cash flow | -13.60M | 39.73% |
About
Founded
2018
Website
Employees
107
